Oct 16, 2026 06:23AM
Aug 25, 2026 10:40AM
Aug 25, 2026 10:40AM
Aug 5, 2026 06:00AM
Jun 12, 2026 06:00AM
Jun 1, 2026 06:00AM
May 29, 2026 06:00AM BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 2026
May 27, 2026 05:00PM
May 27, 2026 05:00PM
May 21, 2026 06:00AM
May 13, 2026 01:28PM
May 13, 2026 01:27PM
May 6, 2026 06:00AM
Apr 29, 2026 06:00AM FDA grants priority review to BeOne's cancer drug combination
Apr 29, 2026 06:00AM
Feb 26, 2026 06:00AM
Jan 6, 2026 01:31PM
Jan 6, 2026 01:30PM
Dec 18, 2025 06:00AM
Dec 18, 2025 06:00AM
Dec 8, 2025 08:00AM BRUKINSA Delivers Landmark 74% 6-Year PFS in Patients with Treatment-Naïve Chronic Lymphocytic Leukemia
Dec 7, 2025 06:00PM
Nov 26, 2025 06:00AM
Nov 26, 2025 06:00AM
Nov 20, 2025 06:00AM
Nov 6, 2025 06:00AM
Oct 13, 2025 06:00AM
Oct 13, 2025 06:00AM BeOne Medicines’ Sonrotoclax Granted Breakthrough Therapy Designation by U.S. FDA
Sep 29, 2025 08:30AM
Sep 11, 2025 08:18AM
Aug 29, 2025 06:00AM
Aug 29, 2025 06:00AM
Aug 11, 2025 04:56PM
Aug 11, 2025 04:55PM
Aug 8, 2025 09:05AM Oncolytics Biotech® Reports Second Quarter Financial Results and Details Clinical Program Plans for Pelareorep
Aug 8, 2025 09:00AM
Aug 8, 2025 09:00AM
Aug 6, 2025 06:00AM
Aug 5, 2025 08:30AM
Jul 31, 2025 06:01AM
Jul 31, 2025 06:00AM
Jul 29, 2025 08:30AM Oncolytics plans FDA talks for pancreatic cancer drug trial
Jul 29, 2025 08:30AM
Jul 23, 2025 09:39AM
Jul 22, 2025 03:33PM
Jul 22, 2025 03:32PM
Jul 16, 2025 08:30AM
Jul 10, 2025 08:30AM
Jul 8, 2025 08:30AM Oncolytics Biotech® Highlights Transformative Pelareorep Survival Data in Multiple Tumors and Commitment to Registration-Enabling Studies
Jun 30, 2025 07:00AM

334,268 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All